DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Takahashi A, Namikawa K, Nakano E, Yamazaki N.
Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma.
J Dermatol 2020;
47 (03) 257-264
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.